The National Institute of Allergy and Infectious Diseases has announced a closed meeting scheduled from January 17 to 24, 2025, to review contract proposals relating to new drug classes for HIV, Hepatitis B, and Tuberculosis. The meeting will be conducted via video at the National Institutes of Health in Rockville, MD. This meeting is closed to the public due to confidentiality concerns, as it may involve sensitive information such as trade secrets and personal data. For more details, interested parties can contact Dr. Barry J. Margulies at the provided email address.
Simple Explanation
The National Institute of Allergy and Infectious Diseases is having an online meeting to talk about new medicines for diseases like HIV, Hepatitis B, and Tuberculosis, but the meeting is private because they need to keep secrets safe.